119-S-4494 Journalist Public Summary
119 · S 4494 American Cures Act
S. 4494 (“American Cures Act”) would create a long-term, inflation-adjusted stream of mandatory funding for NIH, CDC, the Defense Health Program’s research arm, and VA medical research; supporters say it gives labs stable budgets, while critics worry it sidesteps PAYGO rules and adds to deficits; as of May 12, 2026, it’s been sent to the Senate Appropriations Committee.
Public Summary: S. 4494 — American Cures Act (119th Congress)
Headline Summary: A long-term plan to steadily grow federal medical research budgets (NIH, CDC, DoD health research, VA) and shield them from across‑the‑board cuts and year‑to‑year funding swings.
What It Does: The bill would set specific dollar amounts for the National Institutes of Health, the Centers for Disease Control and Prevention, the Department of Defense’s health research program, and the Department of Veterans Affairs’ medical and prosthetics research from fiscal year 2027 through 2036, then continue increasing those amounts by inflation each year after 2037. The money would be “available until expended,” providing multi‑year stability. Supporters frame this as predictable, mandatory funding so researchers can plan long‑term projects without annual budget fights. (durbin.senate.gov)
- Who’s For It: Lead sponsor Sen. Dick Durbin (D‑IL), with Sens. Richard Blumenthal (D‑CT), Tammy Duckworth (D‑IL), and Chris Van Hollen (D‑MD) as original co‑sponsors (as listed on the bill).
- Sponsors say steady, guaranteed funding will speed cures and reduce uncertainty for labs and patients. (durbin.senate.gov)
- Earlier versions of the American Cures Act drew backing from groups like Research!America and the American Heart Association, signaling support among research advocates and patient organizations. (durbin.senate.gov)
- Who’s Against It: Budget watchdogs and some fiscal conservatives often object when Congress creates new mandatory spending streams or wipes costs from PAYGO scorecards, arguing it weakens fiscal guardrails and can add to deficits. (crfb.org)
- Others prefer to fund research through the regular annual appropriations process to preserve yearly oversight and prioritize among competing needs.
What’s Next: As of May 12, 2026, S. 4494 has been read twice and referred to the Senate Committee on Appropriations. If it advances, it would still need a Senate floor vote, House passage, and the President’s signature to become law. (quiverquant.com)
Discussion